this post was submitted on 16 Sep 2023
1158 points (96.2% liked)

Technology

59578 readers
3233 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 1 year ago
MODERATORS
 

Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

you are viewing a single comment's thread
view the rest of the comments
[–] MajesticSloth@lemmy.world 5 points 1 year ago (1 children)

What phase 2 specifically if you don't mind sharing? They mention in this article starting with a phase 1 for celiac and then a phase 1 for MS.

I've also seen so many of these over a couple decades now. I have RA and MS and often times while hope can be important. As Red said, hope is a dangerous thing and can drive a man insane.

[–] Nowyn@sopuli.xyz 4 points 1 year ago (1 children)

I also have really complicated relationship with hope. Mainly, I try not to hope as my body seems to be insanely problematic. I am disabled with multiple autoimmune diseases and genetic syndrome. While objectively I find the advancement in treatment interesting and amazing, I personally try not to hope. It is absolutely exhausting to get your hopes up only for the other shoe to drop.

[–] MajesticSloth@lemmy.world 7 points 1 year ago

Over the years you learn to pick and choose which ones to even read about.

My favorites are when actual new meds are introduced to patients and the majority of the article talks about how much money they expect it to make for the pharmaceutical company.